(Q39264219)

10 September 2017

title

Use of clinical staging in amyotrophic lateral sclerosis for phase 3 clinical trials (English)

1 reference

amyotrophic lateral sclerosis

10 September 2017

main subject

phase III clinical trial

0 references

0 references

author

Carolyn A. Young

5

1 reference

10 September 2017

6

1 reference

10 September 2017

10

1 reference

10 September 2017

Martin R Turner

7

0 references

Ammar Al-Chalabi

9

object named as

Ammar Al-Chalabi

1 reference

10 September 2017

8

P Nigel Leigh

1 reference

10 September 2017

0 references

Rubika Balendra

1

1 reference

10 September 2017

Ashley Jones

2

1 reference

10 September 2017

Naheed Jivraj

3

1 reference

10 September 2017

I Nick Steen

4

1 reference

10 September 2017

language of work or name

English

0 references

publication date

24 January 2014

1 reference

Journal of Neurology, Neurosurgery and Psychiatry

10 September 2017

published in

1 reference

10 September 2017

volume

86

1 reference

10 September 2017

issue

1

1 reference

10 September 2017

page(s)

45-49

1 reference

Amyotrophic lateral sclerosis

10 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-306865

A proposed staging system for amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-306865

Protocol for a double-blind randomised placebo-controlled trial of lithium carbonate in patients with amyotrophic lateral sclerosis (LiCALS) [Eudract number: 2008-006891-31].

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-306865

Lithium in patients with amyotrophic lateral sclerosis (LiCALS): a phase 3 multicentre, randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-306865

El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-306865

The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III).

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-306865

New considerations in the design of clinical trials for amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-306865

Randomized control trials in ALS: lessons learned

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-306865

The natural history of ALS is changing: improved survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-306865

Clinical trials in ALS: what did we learn from recent trials in humans?

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-306865

Therapy development for ALS: lessons learned and path forward

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-306865

Clinical trials: present and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-306865

Clinical diagnosis and management of amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-306865

Clinical features of amyotrophic lateral sclerosis according to the El Escorial and Airlie House diagnostic criteria: A population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-306865

Progression in ALS is not linear but is curvilinear.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-306865

Alteration of nutritional status at diagnosis is a prognostic factor for survival of amyotrophic lateral sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-306865

Hypermetabolism in ALS: correlations with clinical and paraclinical parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-306865

Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: drug, nutritional, and respiratory therapies (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-306865

Percutaneous endoscopic gastrostomy (PEG) in patients with ALS and bulbar dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-306865

Some difficult decisions in ALS/MND.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-306865

21 January 2018

Identifiers

DOI

10.1136/JNNP-2013-306865

1 reference

10 September 2017

1 reference